Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
ABSTRACT Human papillomaviruses (HPVs) are causative agents in around 5% of all cancers, including cervical and oropharyngeal. A feature of HPV cancers is their better clinical outcome compared with non-HPV anatomical counterparts. In turn, the presence of E2 predicts a better clinical outcome in HP...
Guardado en:
Autores principales: | Christian T. Fontan, Dipon Das, Molly L. Bristol, Claire D. James, Xu Wang, Hannah Lohner, Azeddine Atfi, Iain M. Morgan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/602939745ffb40aba6aeb9344b3fc1dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis
por: Ruwen Yang, et al.
Publicado: (2019) -
Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
por: Claire D. James, et al.
Publicado: (2020) -
An Infection-Based Murine Model for Papillomavirus-Associated Head and Neck Cancer
por: Tao Wei, et al.
Publicado: (2020) -
Prevalence of HPV in Mexican Patients with Head and Neck Squamous Carcinoma and Identification of Potential Prognostic Biomarkers
por: Galo Méndez-Matías, et al.
Publicado: (2021) -
Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP)
por: Matthias Balk, et al.
Publicado: (2021)